Large-scale testing (Phase 3)Study completedNCT00111007What this trial is testingA Treatment Combination for Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forMelanoma Bayer 270
Early research (Phase 1)WithdrawnNCT01843738What this trial is testingRadiation Use During Vemurafenib TreatmentWho this might be right forBRAFV600 MutationStage IV Melanoma University of Utah
Testing effectiveness (Phase 2)Study completedNCT00135408What this trial is testingMDX-010 (BMS-734016) Administered With or Without Prophylactic Oral BudesonideWho this might be right forMalignant Melanoma Bristol-Myers Squibb 115
Large-scale testing (Phase 3)Study completedNCT02388906What this trial is testingEfficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 906
Not applicableEnrolling By InvitationNCT06605833What this trial is testingCARDiac Toxicity Following ImmunOtherapy Treatment for MelanomaWho this might be right forMelanoma Stage III or IV Royal Marsden NHS Foundation Trust 60
Not applicableLooking for participantsNCT06784778What this trial is testingObservational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy.Who this might be right forMelanoma MetastaticMelanoma, SkinMelanoma Stage III or IV+1 more Pamgene International B.V. 196
Testing effectiveness (Phase 2)Ended earlyNCT06984328What this trial is testingStudy of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07)Who this might be right forCutaneous MelanomaRelapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID)Metastatic Cutaneous Melanoma (Stage IV) Genmab 1
Testing effectiveness (Phase 2)Ended earlyNCT02587650What this trial is testingCapmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV MelanomaWho this might be right forALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more University of California, San Francisco 1
Not applicableLooking for participantsNCT07050940What this trial is testingAnti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma StudyWho this might be right forMelanoma Metastatic Azienda Ospedaliera di Perugia 35
Testing effectiveness (Phase 2)Study completedNCT00261365What this trial is testingPhase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)Who this might be right forUnresectable Stage III or IV Malignant Melanoma Bristol-Myers Squibb 80
Very early researchStudy completedNCT02320305What this trial is testingMART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by SurgeryWho this might be right forStage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more Mayo Clinic 23
Testing effectiveness (Phase 2)UnknownNCT00086866What this trial is testingVaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With SurgeryWho this might be right forMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 165
Testing effectiveness (Phase 2)Ended earlyNCT02414750What this trial is testingVemurafenib Plus Cobimetinib in Metastatic MelanomaWho this might be right forMetastatic Melanoma Netherlands Working Group on Immunotherapy of Oncology 78
Testing effectiveness (Phase 2)Study completedNCT01950390What this trial is testingIpilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryWho this might be right forStage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7Unresectable Melanoma National Cancer Institute (NCI) 169
Testing effectiveness (Phase 2)Ended earlyNCT03325101What this trial is testingDendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable MelanomaWho this might be right forStage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+2 more Mayo Clinic 7
Early research (Phase 1)Study completedNCT00028431What this trial is testingNovel Adjuvants for Peptide-Based Melanoma VaccinesWho this might be right forMelanoma University of Southern California 19
Large-scale testing (Phase 3)Study completedNCT00016263What this trial is testingDacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant MelanomaWho this might be right forMelanoma (Skin) Genta Incorporated
Testing effectiveness (Phase 2)Ended earlyNCT01316692What this trial is testingAurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV MelanomaWho this might be right forRecurrent MelanomaStage IIIc MelanomaStage IV Melanoma Vanderbilt-Ingram Cancer Center 12
Not applicableStudy completedNCT00974610What this trial is testingStudy of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.Who this might be right forBreast CancerColorectal CancerLung Cancer+2 more Cancer Trials Ireland 803
Early research (Phase 1)Study completedNCT00118313What this trial is testingVaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaWho this might be right forMelanoma (Skin) Craig L Slingluff, Jr